Recent developments in the understanding of the pathophysiology of osteopetrosis

European Journal of Endocrinology

Volumn 134, Issue 2, 1996, Pages 143-156

  Felix, Rolf ^a   Hofstetter, Willy ^a   Cecchini, Marco G ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE II; COLONY STIMULATING FACTOR 1;

ALBERS SCHOENBERG DISEASE; HUMAN; MOUSE; OSTEOCLAST; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0030048510     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1340143     Document Type: Review

References (142)

1. Fawcett DW. The amedullary bones of the Florida manatee (trichecus latirostis). Am J Anat 1942;72:271-309
2. Shimada A, Asada Y, Oura R, Umemura T. Medullary bone of piglets. J Vet Med Sci 1991;53:1009-12
3. Osier LK, Marks Jr SC. Osteopetrosis. In: Rifkin BR, Gay CV editors. Biology and physiology of the osteoclast. London: CRC Press. 1992:433-53
4. Seifert MF, Popoff SN, Jackson ME, MacKay CA, Cielinski M, Marks Jr SC. Experimental studies of osteopetrosis in laboratory animals. Clin Ortop 1993;294:23-33
5. Scheven BAA, Visser JWM, Nijweide PJ. In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Nature 1986;321:79-81
6. Hagenaars CE, van der Kraan AAM, Kawilarang-de Haas EWM.,Visser JWM, Nijweide PJ. Osteoclast formation from cloned pluripotent hemopoietic stem cells. Bone Miner 1989;6:179-89
7. Scheven BAA, Kawilarang-De Haas EWM, Wassenaar AM, Nijweide PJ. Differentiation kinetics of osteoclasts in the periosteum of embryonic bones in vivo and in vitro. Anatom Rec 1986;214:418-23
8. Nicholson GC, Moseley JM, Sexton PM, Mendelsohn FAO, Martin TJ. Abundant calcitonin receptors in isolated rat osteoclasts. J Clin Invest 1986;78:355-60
9. Hofstetter W, Wetterwald A, Cecchini MC, Felix R, Fleisch H, Müller C. Detection of transcripts for the receptor for macrophage colony-stimulating factor, c-fms, in murine osteoclasts. Proc Natl Acad Sci USA 1992;89:9637-41
10. Hofstetter W, Wetterwald A, Cecchini MG, Felix R. Detection of transcripts and binding sites for colony-stimulating factor-1 during some development Bone 1995;17:145-51
11. Weir EC, Horowitz MC, Baron R, Centrella M, Kacinski BM, Insogna KL. Macrophage colony-stimulating factor release and receptor expression in bone cells. J Bone Miner Res 1993;8:1507-18
12. Stanley ER. Colony stimulating factor-1 (macrophage colony stimulating factor). In: Thomson A, editor. The cytokine handbook. London: Academic Press, 1994:387-418
13. Malkani K, Luxembourger MM, Rebel A. Cytoplasmic modifications at the contact zone of osteoclasts and calcified tissue in the diaphyseal growing plate of foetal guinea-pig tibia. Calcif Tissue Res 1973;11:258-64
14. King GJ, Holtrop ME. Actin-like filaments in bone cells of cultured mouse calvaria as demonstrated by binding to heavy meromyosin. J Cell Biol 1975;66:445-51
15. Baron R, Ravesloot JH, Neff L, Chakraborty M, Chatterjee D, Lomri A, et al. Cellular and molecular biology of the osteoclast. In: Noda M. editor. Cellular and molecular biology of bone. London: Academic Press, 1993:445-95
16. Delaissé JM, Vaes G. Mechanism of mineral solubilization and matrix degradation in osteoclastic bone resorption. In: Rifkin R, Gay CV, editors. Biology and physiology of the osteoclast. London: CRC Press, 1992:289-314
17. Garrett RI, Boyce BF, Oreffo ROC, Bonewald L, Poser J, Mundy GR. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J Clin Invest 1990:85:632-9
18. Owen M, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors. In: Cell and molecular biology of vertebrate hard tissues [Ciba Foundation Symposium]. Vol 136. Chichester: Wiley, 1988:42-60
19. Burger EH, Van der Meer JWM, Nijweide PJ. Osteoclast formation from mononuclear phagocytes: role of bone-forming cells. J Cell Biol 1984;99:1901-6
20. Suda T, Takahashi N, Martin TJ. Modulation of osteoclast differentiation. Endocr Rev 1992;13:66-80
21. Takahashi N, Akatsu T, Udagawa N, Sasaki T, Yamaguchi A, Moseley JM, et al. Osteoblastic cells are involved in osteoclast formation. Endocrinology 1988;123:2600-2
22. 1. J Pathol 1983;139: 383-97
23. McSheehy PMJ, Chambers TJ. Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. Endocrinology 1986; 119:1654-9
24. 3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption. J Clin Invest 1987;80: 425-9
25. Thomson BM, Saklatvala J, Chambers TJ. Osteoblasts mediate intericukin 1 stimulation of bone resorption by rat osteoclasts. J Exp Med 1986;164:104-12
26. Thomson BM, Mundy GR, Chambers TJ. Tumor necrosis factors α and β induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 1987;138:775-9
27. Sakamoto S, Sakamoto M. Osteoblast collagenase: collagenase synthesis by clonally derived mouse osteogenic (MC3T3-E1) cells. Biochem Int 1984;9:51-8
28. Heath JK, Atkinson SJ, Meikle MC, Reynolds JJ. Mouse osteoblasts synthesize collagenase in response to bone resorbing agents. Biochim Biophys Acta 1984;802:151-4
29. Partridge NC, Jeffrey JJ, Ehlich LS, Teitelbaum SL, Fliszar C, Welgus HG, et al. Hormonal regulation of the production of collagenase inhibitor activity by rat osteogenic sarcoma cells. Endocrinology 1987;120:1956-62
30. Chambers TJ, Thomson BM, Fuller K. Effect of substrate composition on bone resorption by rabbit osteoclasts. J Cell Sci 1984;70:61-71
31. 2 in bone of osteopetrotic (mi/mi) mice. Endocrinology 1983;112:945-50
32. Jilka RL. Stimulation of collagenolytic enzyme release from cultured bone cells of normal and osteopetrotic (mi/mi) mice by parathyroid hormone and lipopolysaccharide. Bone Miner 1989;6:277-87
33. Heath JK, Reynolds JJ, Meikle MC. Osteopetrotic (grey-lethal) bone produces collagenase and TIMP in organ culture: regulation by vitamin A. Biochem Biophys Res Commun 1990;168:1171-6
34. Gopal T, Leipold HW, Dennis SM. Hydatidiform moles in Holstein cattle. Vet Rec 1980;107:395-7
35. Lees GE, Sautter JH. Anemia and osteopetrosis in a dog. J Am Vet Med Assoc 1979;175:820-4
36. Smits B, Bubenik CA. Congenital osteopetrosis in white-tailed deer (Odocoileus virginianus). J Wildlife Dis 1990;26:567-71
37. Marks Jr SC. Congenital osteopetrotic mutations as probes of the origin, structure and function of osteoclasts. Clin Ortop 1984;1989:239-63
38. Walker DG. Spleen cells transmit osteopetrosis in mice. Science 1975;190:785-7
39. Walker DG. Osteopetrosis cured by temporary parabiosis. Science 1973;180:875
40. Marks Jr SC, Walker DG. The hematogenous origin of osteoclasts: experimental evidence from osteopetrotic (microphthalmic) mice treated with spleen cells from beige mouse donors. Am J Anat 1981;161:1-10
41. Seifert MF, Marks Jr SC. Congenially osteosclerotic (oc/oc) mice are resistant to cure by transplantation of bone marrow or spleen cells from normal littermates. Tissue Cell 1987;19:29-37
42. Wiktor-Jedrzejczak W, Szczylik C, Ratajczak MZ, Ahmed A. Congenital murine osteopetrosis inherited with osteosclerotic (oc) gene: hematological characterization Exp Hematol 1986;14:819-26
43. Marks Jr SC, Seifert MF, McGuire JL. Congenitally osteopetrotic (op/op) mice are not cured by transplants of spleen or bone marrow cells from normal littermates. Metab Bone Dis Relat Res 1984;5:183-6
44. Wiktor-Jedrzejczak W, Ahmed WA, Szczylik C, Skelly RR. Hematological characterization of congenital osteopetrosis in op/op mouse. Possible mechanism for abnormal macrophage differentiation. J Exp Med 1982;156:1516-27
45. Marks Jr SC. Studies of the mechanism of spleen cell cure for osteopetrosis in ia rats: appearance of osteoclasts with ruffled borders. Am J Anat 1978;151:119-29
46. Marks Jr SC, Schneider GB. Transformations of osteoclast phenotype in ia rats cured of congenital osteopetrosis. J Morphol 1982;174:141-7
47. Marks Jr SC. Osteopetrosis in the toothless (tl) rat: presence of osteoclasts but failure to respond to parathyroid extract or to be cured by infusion of spleen or bone marrow cells from normal littermates. Am J Anat 1977;149:289-97
48. Philippart C, Arys A, Dourov N. Effects of bone marrow transplantation on impacted dental germs in osteopetrotic op/op rats. J Oral Pathol 1989;18:163-6
49. Popoff SN, Marks Jr SC. Congenially osteosclerotic (os/os) rabbits are not cured by bone marrow transplantation from normal littermates. Am J Anat 1991;192:274-80
50. Marks CR, Seifert MF, Marks Jr SC. Osteoclast populations in congenital osteopetrosis: additional evidence of heterogeneity. Metab Bone Dis Relat Res 1984;5:259-64
51. Holtrop ME, Cox KA, Eilon G, Simmons HA, Raisz LG. The ultrastructure of osteoclasts in microphthalmic mice. Metab Bone Dis Relat Res 1981;3:123-9
52. Marks Jr SC. Morphological evidence of reduced bone resorption in osteopetrotic (op) mice. Am J Anat 1982;163:157-67
53. Marks Jr SC. Pathogenesis of osteopetrosis in the ia rat: reduced bone resorption due to reduced osteoclast function. Am J Anat 1973;138:165-90
54. Seifert MF, Popoff SN, Marks Jr SC. Skeletal biology in the toothless (osteopetrotic) rat. Am J Anat 1988;183:158-65
55. Marks Jr SC, Popoff SN. Osteoclast biology in the osteopetrotic (op) rat. Am J Anat 1989;186:325-34
56. Cielinski MJ, Marks Jr SC. Neonatal reductions in osteoclast number and function account for the transient nature of osteopetrosis in the rat mutation microphthalmia blanc (mib). Bone 1994;15:707-15
57. Marks Jr SC, Seifert MF, Fox RR. The osteopetrotic rabbit: general and skeletal features of a new outbred stock. Bone 1986;7:359-64
58. Marks Jr SC, Seifert MF. The development and structure of osteoclasts in osteopetrosis. In: Butler WT, editor. The chemistry and biology of mineralized tissues. Birmingham, AL: 1985:408-10
59. Seifert MF, Marks Jr SC. Morphological evidence of reduced bone resorption in the osteosclerotic (oc) mouse. Am J Anat 1985;172:141-53
60. Marks Jr SC, Mackay CA, Seifert MF. The osteopetrotic rabbit: skeletal cytology and ultrastructure. Am J Anat 1987;178:300-7
61. Thesingh CW, Scherft JP. Fusion disability of embryonic osteoclast precursor cells and macrophages in the microphthalmic osteopetrotic mouse. Bone 1985;6:43-52
62. Walker DG. Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science 1975;190:784-5
63. Walker DG. Control of bone resorption by hematopoietic tissue. J Exp Med 1975;142:651-63
64. Udagawa N, Sasaki T, Akatsu T, Takahashi N, Tanaka S. Tamura T, et al. Lack of bone resorption in osteosclerotic (oc/oc) mice is due to a defect in osteoclast progenitors rather than the local microenviroinment provided by osteoblastic cells. Biochem Biophys Res Commun 1992,184:67-72
65. Shalhoub V, Jackson ME, Lian JB, Stein GS, Marks Jr SC. Gene expression during skeletal development in three osteopetrotic rat mutations. J Biol Chem 1991;266:9847-56
66. Puzas JE, Ishibe M. Osteoblast/osteoclast coupling. In: Rifkin BR, Gay CV. editors. Biology and physiology of the osteoclast. London: CRC Press, 1992:337-56
67. Yoshida H, Hayashi SI, Kunisada T, Ogawa M, Nishikawa S, Okamura H, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990;345:442-4
68. Felix R, Hofstettter W, Stutzer A, Fleisch H. Impairment of macrophage colony-stimulating factor (M-CSF) production in the osteopetrotic op/op mouse (abstract). Calcif Tissue Int 1988;42 Suppl:A17
69. Felix R, Cecchini MG, Hofstetter W, Elford PR, Stutzer A, Fleisch H. Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. J Bone Miner Res 1990;5:781-9
70. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW, Ahmend-Ansari A, Sell KW, Pollard JW, et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci USA 1990;87:4828-32
71. Felix R, Cecchini MG, Fleisch H. Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 1990;127:2592-4
72. Kodama H, Yamasaki A, Nose M, Niida S, Ohgame Y, Abe M, et al. Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med 1991;173:269-72
73. Wiktor-Jedrzejczak W, Urbanowska E, Szperl M. Granulocyte-macrophage colony-stimulating factor corrects macrophage deficiencies, but not osteopetrosis, in the colony-stimulating factor-1-deficient op/op mouse. Endocrinology 1994;134:1932-5
74. Kodama H, Yamasaki A, Abe M, Niida S, Hakeda Y, Kawashima H. Transient recruitment of osteoclasts and expression of their function in osteopetrotic (op/op) mice by single injection of macrophage colony-stimulating factor. J Bone Miner Res 1993;8:45-50
75. Fuller K, Owens JM, Jagger CJ, Wilson A, Moss R, Chambers TJ. Macrophage colony-stimulating factor stimulates surviral and chemotactic behaviour in isolated osteoclasts. J Exp Med 1993;178:1733-44
76. Niida S, Amizuka N, Hara F, Ozawa H, Kodama H. Expression of Mac-2 antigen in the preosteoclast and osteoclast identified in the op/op mouse injected with macrophage colony-stimulating factor. J Bone Miner Res 1994;9:873-881
77. Antonioli-Corboz V, Cecchini MG, Felix R, Fleisch H, van der Pluijm G, Löwik CWGM. Effect of macrophage colony-stimulating factor on in vitro osteoclast generation and bone resorption. Endocrinology 1992;130:437-42
78. 3. J Bone Miner Res 1994;9:401-7
79. Takahashi N, Udagawa N, Akatsu T, Tanaka H, Isogai Y, Suda T. Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local microenvironment provided by osteoblastic cells. Endocrinology 1991;128:1792-6
80. Kodama H, Nose M, Niida S, Yamasaki A. Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J Exp Med 1991;173:1291-4
81. Hattersley G, Owens J, Flanagan AM, Chambers TJ. Macrophage colony stimulating factor (M-CSF) is essential for osteoclast formation in vitro. Biochem Biophys Res Commun 1991;177:526-31
82. Tanaka S, Takahashi N, Udagawa N, Tamura T, Akatsu T, Stanley ER, et al. Macrophage colony-stimulating factor is indispensible for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 1993;91:257-63
83. Price LKH, Choi HU, Rosenberg L, Stanley ER. The predominant form of secreted colony stimulating factor-1 is a proteoglycan. J Biol Chem 1992;267:2190-9
84. Suzu S, Ohtsuki T, Yanai N, Takatsu Z, Kawashima T, Takaku F. et al Identification of a high molecular weight macrophage colony-stimulating factor as a glycosaminoglycan-containing species. J Biol Chem 1992;267:4345-8
85. Rettenmier CW, Roussel MF, Ashmun RA, Ralph P, Price K, Sherr CJ. Synthesis of membrane-bound colony-stimulating factor-1 (CSF-1) and downmodulation of CSF-1 receptors in NIH 3T3 cells transformed by cotransfection of the human CSF-1 and c-fms (CSF-1 receptor) genes. Mol Cell Biol 1987;7:2378-87
86. Pollard JW, Bartocci A, Arceci R, Orlofsky A, Ladner MB, Stanley ER. Apparent role of the macrophage growth factor, CSF-1. in placental development. Nature 1987;330:484-6
87. Regenstreif LJ, Rossant J. Expression of the c-fms protooncogene and of the cytokine, CSF-1, during mouse embryogenesis. Dev Biol 1989;133:284-94
88. Wiktor-Jedrzejczak W, Ratajczak MZ, Ptasznik A, Sell KW, Ahmed-Ansari A, Ostertag W. CSF-1 deficiency in the op/op mouse has differential effects on macrophage populations and differentiation stages. Exp Hematol 1992;20:1004-10
89. Naito M, Hayashi SI, Yoshida H, Nishikawa SI, Schultz LD, Takahashi K. Abnormal differentiation of tissue macrophage populations in "osteopetrosis" (op) mice defective in the production of macrophage colony-stimulating factor. Am J Pathol 1991;139:657-66
90. Cecchini MG, Dominguez MG, Mocci S, Wetterwald A, Felix R, Fleisch H, et al. Role of colony-stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 1994;120:1357-72
91. Marks SC, Lane PW. Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J Hered 1976;67:11-8
92. Wink CS, Sarpong DF, Bruck RD. Tibial dimensions before and during the recovery phase in the osteopetrotic mutant mouse. Acta Anat 1991;141:174-81
93. Begg SK, Radley JM, Pollard JW, Chisholm OT, Stanley ER, Bertoncello I. Delayed hematopoietic development in osteopetrotic (op/op) mice. J Exp Med 1993;177:237-42
94. Marks SC, Wojtowicz A, Szperl M, Urbanowska E, MacKay CA, Wiktor-Jedrzejczak W, et al. Administration of colony stimulating factor-1 corrects some macrophage, dental, and skeletal defects in an osteopetrotic mutant (toothless, tl) in the rat. Bone 1992;13:89-93
95. Marks Jr SC, MacKay CA, Jackson ME, Larson EK, Cielinski MJ, Stanley ER, et al. The skeletal effects of colony-stimulating factor-1 in toothless (osteopetrotic) rats: persistent metaphyseaf sclerosis and the failure to restore subepiphyseal osteoclasts. Bone 1993;14:675-80
96. Sundquist KT, Cecchini MG, Marks Jr SC. Colony-stimulating factor-1 injections improve, but do not cure skeletal sclerosis in osteopetrotic (op) mice. Bone. 1995;16:29-46
97. Chambers TJ, Loutit JF. A functional assessment of macrophages from osteopetrotic mice. J Pathol 1979;129:57-63
98. Minkin C. Defective macrophage chemotaxis in osteopetrotic mice. Calcif Tissue Int 1981;33:677-8
99. Graves III L, Jilka RL. Comparison of bone and parathyroid hormone as stimulators of osteoclast development and activity in calvarial cell cultures from normal and osteopetrotic (mi/mi) mice. J Cell Physiol 1990;145:102-9
100. Hodgkinson CA, Moore KJ, Nakayama A, Steingrimsson E, Copeland NG, Jenkins NA. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 1993;74:395-404
101. Abe E, Katagiri T, Tsuji M, Tamura T, Tanihara M, Yokose S, et al. The localization and function of mi gene in osteoclast formation (Abstract). J Bone Miner Res 1994;9 Suppl 1:S226
102. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, et al. Oncogenes and signal transduction. Cell 1991;64:281-302
103. Cooper JA. The src family of protein-tyrosine kinases. In: Kemp B, Alewood PF, editors. Peptades and protein phosphorylation. Boca Raton. FL: CRC Press, 1989:85-113
104. Kypta RM, Goldberg W, Ulug ET, Courtneidge SA. Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell 1990;62:481-92
105. Courtneidge SA, Dhand R, Pilat D, Twamley GM, Waterfield MD, Roussel MF. Activation of src family kinases by colony stimuiating faclor-1, and their association with its receptor. EMBO J 1993;12:943-50
106. src substrate. Mol Cell Biol 1991;11:5113-24
107. c-src in association with intracellular membranes. J Cell Biol 1992;119:1003-13
108. c-src, preferentially on ruffled border membranes. FEBS Lett. 1992;313:85-9
109. Soriano P, Montgomery C, Geske R, Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 1991;64:693-702
110. c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 1992;90:1622-7
111. Lowe C, Yoneda T, Boyce BF, Chen H, Mundy GR. Osteopetrosis in src-deficient mice is due to an autonomous defect of osteoclasts. Proc Natl Acad Sci USA 1993;90:4485-9
112. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991;1072:129-57
113. Rüther U, Komitowski D, Schubert FR, Wagner EF. c-fos expression induces bone tumors in transgenic mice. Oncogene 1989;4:861-5
114. Wang ZQ, Grigoriadis AE, Möhle-Steinlein U, Wagner EF. A novel target cell for c-fos induced oncogenesis: development of chondrogenic tumours in embryonic stem cell chimeras. EMBO J 1991;10:2437-50
115. Takao S, Sakai N, Hatano M, Koizumi T, Hanioka K, Rüther U, et al. IgG response is impaired in H2-c-fos transgenic mice. Int Immunol 1991;3:369-75
116. Wang ZQ, Ovitt C, Grigoriadis AE, Möhle-Steinlein U, Rüther U, Wagner EF. Bone and haematopoietic defects in mice lacking c-fos. Nature 1992;360:741-5
117. Johnson RS, Spiegelman BM, Papaioannou V. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 1992;71:577-86
118. Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 1994;266:443-8
119. Ballet J, Griscelli C, Courtris C, Milhaud G, Maroteaux P. Bone-marrow transplantation in osteopetrosis. Lancet 1977;2:1137
120. Coccia PF, Krivit W, Cervenka J, Clawson C, Kersey JH, Kim TH, et al. Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med 1980;302:701-8
121. Kaplan FS, August CS, Fallon MD, Dalinka M, Axel L, Haddad JG. Successful treatment of infantile malignant osteopetrosis by bone-marrow transplantation. J Bone Joint Surg 1988;70A: 617
122. Sieff C, Levinsky R, Rogers D, Muller K, Chessells J, Pritchard J, et al. Allogeneic bone-marrow transplantation in infantile malignant osteopetrosis. Lancet 1983;1:437-41
123. Sorell M, Kapoor N, Kirkpatrick D, Rosen JF, Chaganti RSK, Lopez C, et al. Marrow transplantation for juvenile osteopetrosis. Am J Med 1981;70:1280-7
124. Barnicot NA. Some data on the effect of parathormone on the grey-lethal mouse. J Anat 1945;79:83
125. Walker DG. Experimental osteopetrosis. Clin Orthop 1973;97: 158-74
126. Glorieux FH, Pettifor JM, Marie PJ, Delvin EE, Travers R, Shepard N. Induction of bone resorption by parathyroid hormone in congenital malignant osteopetrosis. Metab Bone Dis Relat Res 1981;3:143-50
127. Zerwekh JE, Marks Jr SC, McGuire JL. Elevated serum 1,25-dihydroxyvitamin D in osteopetrotic mutations in three species. Bone Miner 1987;2:193-9
128. Monaghan BA, Kaplan FS, August CS, Fallon MD, Flannery DB. Transient infantile osteopetrosis. J Pediatr 1991;22:252-6
129. Key L, Carnes D, Cole S, Holtrop M, Bar-Shavit Z, Shapiro F, et al. Treatment of congenital osteopetrosis with high-dose calcitriol. N Engl; J Med 1984;310:409-15
130. Popoff SN, McGuire JL, Zerwekh JE, Marks Jr SC. Treatment of congenital osteopetrosis in the rabbit with high-dose 1,25-dihydroxyvitamin D. J Bone Miner Res 1989;4:57-67
131. Grise MA, Marks SC, MacKay CA, Popoff SN. Effects of 1,25 dihydroxyvitamin D on osteoclast number and cytochemistry in normal and osteopetrotic (os) rabbits. Am J Anat 1990;189:261-6
132. Beard CJ, Key L, Newburger PE, Ezekowitz RAB, Arceci R, Miller B, et al. Neutrophil defect associated with malignant infantile osteopetrosis. J Lab Clin Med 1986;108:498-505
133. Reeves JD, August CS, Humbert JR, Weston WL. Host defense in infantile osteopetrosis. Pediatrics 1979;64:202-6
134. Key Jr LL, Ries WL, Rodriquez RM, Hatcher HC. Recombinant human interferon gamma therapy for osteopetrosis. J Pediatr 1992;2:119-24
135. Bollerslev J. Autosomal dominant osteopetrosis: bone metabolism and epidemiological, clinical, and hormonal aspects. Endocr Rev 1989;10:45-67
136. Bollerslev J, Nielsen HK, Larsen HF, Mosekilde L. Biochemical evidence of disturbed bone metabolism and calcium homeostasis in two types of autosomal dominant osteopetrosois. Acta Med Scand 1988;224:479-83
137. Bollerslev J, Marks Jr SC, Pockwinse S, Kassem M, Brixen K, Steiniche T, et al. Ultrastructural investigations of bone resorptive cells in two types of autosomal dominant osteopetrosis. Bone 1993;14:865-9
138. Sly WS, Hewett-Emmett D, Whyte MP, Yu YSL, Tashian RE. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci 1983;80:2752-6
139. Roth DE, Venta PJ, Tashian RE, Sly WS. Molecular basis of human carbonic anhydrase II deficiency. Proc Natl Acad Sci 1992;89:1804-8
140. Yamamoto T, Kurihara N, Yamaoka K, Ozono K, Okada M, Yamamoto K, et al. Bone marrow-derived osteoclast-like cells from a patient with craniometaphyseal dysplasia lack expression of osteoclast-reactive vacuolar proton pump. J Clin Invest 1993;91:362-7
141. Orchard PJ, Dahl N, Aukerman SL, Blazar, Key Jr LL. Circulating macrophage colony-stimulating factor is not reduced in malignant osteopetrosis. Exp Hematol 1992;20: 103-5
142. Bollerslev J, Steiniche T, Melsen F, Mosekilde L. Structural and histomorphometric studies of iliac crest trabecular and cortical bone in autosomal dominant osteopetrosis: a study of two radiological types. Bone 1989;10:19-24